SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18399167
Source:
http://linkedlifedata.com/resource/pubmed/id/18399167
Search
Subject
(
45
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026764
,
umls-concept:C0040808
,
umls-concept:C0087111
,
umls-concept:C0678951
,
umls-concept:C1280500
,
umls-concept:C1332828
pubmed:issue
10
pubmed:dateCreated
2008-4-10
pubmed:abstractText
To study the distribution of different genotypes of CYP2C19 in multiple myeloma (MM), and investigate the effect of its polymorphism on efficacy of thalidomide-based regimens for the treatment of MM and discuss the role of antiangiogenesis in MM.
pubmed:language
chi
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8212398
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases
,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2C19 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0253-2727
pubmed:author
pubmed-author:HouJianJ
,
pubmed-author:LiYong-HuaYH
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
651-4
pubmed:meshHeading
pubmed-meshheading:18399167-Adult
,
pubmed-meshheading:18399167-Aged
,
pubmed-meshheading:18399167-Aged, 80 and over
,
pubmed-meshheading:18399167-Antineoplastic Agents
,
pubmed-meshheading:18399167-Aryl Hydrocarbon Hydroxylases
,
pubmed-meshheading:18399167-Female
,
pubmed-meshheading:18399167-Humans
,
pubmed-meshheading:18399167-Male
,
pubmed-meshheading:18399167-Middle Aged
,
pubmed-meshheading:18399167-Multiple Myeloma
,
pubmed-meshheading:18399167-Polymorphism, Restriction Fragment Length
,
pubmed-meshheading:18399167-Thalidomide
,
pubmed-meshheading:18399167-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
[Effect of CYP2C19 gene polymorphism on efficacy of thalidomide-based regimens for the treatment of multiple myeloma].
pubmed:affiliation
Department of Hematology, Chang Zheng Hospital, the Second Military Medical University, Shanghai 200003, China.
pubmed:publicationType
Journal Article
,
English Abstract